Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,374 | 491 | 85.4% |
| Travel and Lodging | $1,823 | 6 | 11.6% |
| Education | $445.53 | 6 | 2.8% |
| Gift | $16.65 | 1 | 0.1% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $3,140 | 42 | $0 (2020) |
| Astellas Pharma US Inc | $1,739 | 68 | $0 (2024) |
| SN Holdings, LLC | $1,150 | 8 | $0 (2024) |
| ABBVIE INC. | $1,007 | 52 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $678.33 | 27 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $595.74 | 25 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $463.45 | 8 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $377.85 | 20 | $0 (2024) |
| Axonics, Inc. | $362.25 | 8 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $354.89 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,711 | 69 | ABBVIE INC. ($276.66) |
| 2023 | $2,414 | 70 | SN Holdings, LLC ($392.00) |
| 2022 | $2,295 | 75 | Astellas Pharma US Inc ($341.33) |
| 2021 | $1,972 | 68 | SN Holdings, LLC ($471.85) |
| 2020 | $653.23 | 34 | Astellas Pharma US Inc ($200.96) |
| 2019 | $3,457 | 80 | NeoTract Inc. ($2,316) |
| 2018 | $1,816 | 62 | NeoTract Inc. ($804.43) |
| 2017 | $1,341 | 55 | Astellas Pharma US Inc ($428.95) |
All Payment Transactions
513 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/16/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $115.06 | General |
| Category: Urology | ||||||
| 12/12/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $43.63 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Oncology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: UROLOGY | ||||||
| 11/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $33.62 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: HORMONE THERAPY | ||||||
| 09/30/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/23/2024 | BLUEWIND MEDICAL | — | Food and Beverage | In-kind items and services | $29.12 | General |
| 09/16/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: ONCOLOGY | ||||||
| 09/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Oncology | ||||||
| 08/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,655 | 7,434 | $1.9M | $382,011 |
| 2022 | 36 | 4,049 | 5,488 | $1.6M | $397,928 |
| 2021 | 51 | 3,779 | 5,583 | $1.5M | $513,669 |
| 2020 | 50 | 4,119 | 10,445 | $1.7M | $639,668 |
All Medicare Procedures & Services
176 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 23 | 1,260 | $124,740 | $81,305 | 65.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 581 | 735 | $441,180 | $72,667 | 16.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 147 | 187 | $230,010 | $37,806 | 16.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 143 | 534 | $160,200 | $27,498 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 204 | 204 | $159,120 | $25,553 | 16.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 251 | 276 | $154,560 | $25,441 | 16.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 25 | 161 | $115,920 | $21,787 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 260 | 286 | $125,840 | $19,763 | 15.7% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 27 | 87 | $52,635 | $9,334 | 17.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 600 | 733 | $43,980 | $6,792 | 15.4% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 70 | 72 | $38,840 | $6,314 | 16.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 18 | 86 | $36,980 | $6,046 | 16.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 133 | $31,920 | $5,292 | 16.6% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 84 | $22,680 | $3,337 | 14.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 18 | 18 | $21,240 | $3,271 | 15.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 21 | 21 | $15,330 | $2,649 | 17.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 24 | $13,920 | $2,612 | 18.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 753 | 1,117 | $9,649 | $2,438 | 25.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 20 | 45 | $13,950 | $2,435 | 17.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 43 | 84 | $15,120 | $2,429 | 16.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 23 | 23 | $12,535 | $2,335 | 18.6% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 43 | $7,310 | $2,196 | 30.0% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 12 | 859 | $8,590 | $1,897 | 22.1% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 13 | 15 | $3,240 | $1,892 | 58.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 30 | $13,200 | $1,419 | 10.7% |
About Dr. Timothy Lesser, MD
Dr. Timothy Lesser, MD is a Urology healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053436550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Lesser, MD has received a total of $15,659 in payments from pharmaceutical and medical device companies, with $1,711 received in 2024. These payments were reported across 513 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($13,374).
As a Medicare-enrolled provider, Lesser has provided services to 15,602 Medicare beneficiaries, totaling 28,950 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 176 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Torrance, CA
- Active Since 03/21/2007
- Last Updated 04/04/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1053436550
Products in Payments
- UroLift (Device) $2,099
- UROLIFT (Device) $1,155
- XTANDI (Drug) $707.43
- PROVENGE (Drug) $694.25
- BOTOX (Biological) $677.72
- Myrbetriq (Drug) $529.41
- NEOX (Medical Supply) $512.49
- PROLARIS (Device) $376.97
- Axonics (Device) $362.25
- Nubeqa (Drug) $348.81
- ORGOVYX (Drug) $344.22
- SPY Technology (Device) $300.08
- GEMTESA (Drug) $252.91
- ERLEADA (Drug) $221.26
- KEYTRUDA (Biological) $216.52
- XIAFLEX (Biological) $213.26
- LUPRON DEPOT (Drug) $211.23
- Natesto (Drug) $182.39
- ELIGARD (Drug) $180.24
- Stravix (Biological) $174.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Torrance
Dr. Alec Koo, M.d, M.D
Urology — Payments: $304,742
Dr. Kambiz Dardashti, Md, MD
Urology — Payments: $104,595
Dr. Lawrence Flechner, M.d., Ph.d, M.D., PH.D
Urology — Payments: $23,498
Garrett Matsunaga, M.d, M.D
Urology — Payments: $17,196
Shelby Morrisroe, M.d, M.D
Urology — Payments: $11,710
Royal Park, M.d, M.D
Urology — Payments: $11,696